Invention Grant
- Patent Title: Transglutaminase for inhibiting angiogenesis
- Patent Title (中): 用于抑制血管发生的转谷氨酰胺酶
-
Application No.: US10344084Application Date: 2001-08-08
-
Publication No.: US07704943B2Publication Date: 2010-04-27
- Inventor: Martin Griffin , Richard Jones
- Applicant: Martin Griffin , Richard Jones
- Applicant Address: GB Birmingham
- Assignee: Aston University
- Current Assignee: Aston University
- Current Assignee Address: GB Birmingham
- Agency: Morrison & Foerster LLP
- Priority: GB0019302.9 20000808
- International Application: PCT/GB01/03574 WO 20010808
- International Announcement: WO02/11747 WO 20020214
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/04 ; C07K14/00
Abstract:
The present invention relates to use of a transglutaminase in the preparation of a medicament for inhibiting angiogenesis. Preferably, the transglutaminase is a human tissue transglutaminase. Advantageously, the medicament is for treating cancer, rheumatoid arthritis, retinopathy and/or psoriasis. Additionally, the invention relates to compositions comprising a transglutaminase in an amount sufficient to inhibit angiogenesis.
Public/Granted literature
- US20040028674A1 Biological materials and the use thereof for the treatment of disease Public/Granted day:2004-02-12
Information query
IPC分类:
